Why weight-loss drug Ozempic is getting Wall St attention

<p><strong>Each week BusinessDesk and the NZ Herald’s Cooking the Books podcast tackles a different money problem. Today, it’s the trends fund managers are watching, and banking on. Hosted by Frances Cook.</strong></p> <p>They say that change is the only constant, which is particularly true in the investing world. <br>One moment there’s a hot stock rocketing in price, the next minute, the company is down again, and it’s on to the next. <br>To invest well amongst all the noise means the ability to step back, take the long view, and decide what’s actually a trend that’s likely to last, and keep that business making money. <br>That’s exactly what fund managers do, and there are some spicy choices that have caught their attention recently, including weight loss drugs like Ozempic, and the change towards renewable electricity. <br>So what are they watching, and should you be doing the same? <br>For the latest podcast, I talked to Nathan Field, global equities portfolio manager for Generate. </p> <p>If you have a question about this podcast, or a question you'd like answered in the next one, come and talk to me about it.</p> <p>I'm on <a href="https://www.facebook.com/FrancesCookNZ/">Facebook here</a>, <a href="https://www.instagram.com/francescooknz/">Instagram her</a>e, and <a href="https://twitter.com/FrancesCook">Twitter here</a>.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>